12 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
detailed application instructions ... suspension 4–6 mL ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Single Syringe Adenosine - Instructions
1) Dilute 6-12 mg of adenosine in a syringe for a total
Syringe Adenosine - Instructions ... total volume: 20 mL ... Syringe #Adenosine #Instructions ... #pharmacology # ... SVT #cardiology #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
100 cells/mm3 g/mL ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
if MIC<0.12 ug/ml ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
MC: CNS CSF: • ... osteoarticular, pulmonary, ocular ... blood cultures Candidiasis ... colonization Candidiasis ... Fungal #Diagnosis #Management
Eosinophilic Esophagitis (EoE) - Topical Corticosteroids
 • Liquid - Budesonide - 1 mg PO BID -
Fluticasone 880 mcg ... ingestion unless oral Candidiasis ... Corticosteroids #management ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Castleman’s Disease (MCD ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
consultation to guide management ... Neurosyphilis, Otic, or Ocular ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
The ganciclovir ocular ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
, 2 doses (0.5 mL ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology